Cardiovascular diseases cause more deaths in the world. Atherosclerotic
plaques cause thrombus formation in the blood vessels leads to impediment in the
vascular lumen can create a complete blockage of the blood vessels which increases the
risk of developing coronary artery disease. The biomarker is used to assess the
biological process and pharmacological responses of the drugs to a targeted
intervention. It is used to identify the disease progression burden among the affected
population. The cardiovascular biomarkers include B-type natriuretic peptide, urinary
NGAL, troponin, C-reactive protein, N-terminal prohormone BNP, myeloperoxidase,
lipoprotein-associated phospholipase A2, cytokine IL-37, troponin, fibrinogen,
metalloproteinase-1, and cystatin C is used to predict the risk of progression of
cardiovascular diseases.
Keywords: Biomarker, Cardiovascular Disease, Coronary Artery Disease, Risk
Prediction, Therapeutic Interventions.
